Evaluating a Statewide Pilot Syringe Access Program for Injection Drug Users through Pharmacies in California
Most states in the USA have already overturned or never had laws prohibiting syringes to be sold to injection drug users (IDUs) without a prescription. The goal of selling syringes to IDUs without a prescription is to curtail the transmission of blood-borne viruses such as human immunodeficiency virus, hepatitis C virus, and hepatitis B virus by providing sufficient access to sterile syringes to obviate the need for sharing blood-contaminated syringes. In at least two states (New York and Connecticut), the change in legislation was accompanied by successful impact evaluations showing reductions in syringe sharing without increasing harm.1–10 California passed legislation (Senate Bill [SB] 1159) in 2004 to create a pilot disease prevention demonstration project (DPDP) between January 1, 2005 and December 31, 2010 that would allow pharmacists to sell syringes without prescriptions. The bill mandated that a comprehensive evaluation be completed and submitted to the Legislature and Governo ...
- Fuller CM, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S77–82. CrossRef
- Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97(1): 117–24. CrossRef
- Pouget ER, Deren S, Fuller CM, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic. 2005; 39: 471–7. CrossRef
- Cleland CM, Deren S, Fuller CM, et al. Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Educ Behav. 2007; 34(2): 390–403. CrossRef
- Deren S, Cleland CM, Fuller C, Kang SY, Des Jarlais DC, Vlahov D. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary finding. AIDS Behav. 2006; 10(6): 717–21. CrossRef
- Wright-De Agüero L, Weinstein B, Jones TS, Miles J. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers’ practices. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(Suppl 1): S102–10.
- Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles and syringes on community pharmacies’ needle and syringe sales—Connecticut, 1992–1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 10: 73–81.
- Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs LJ, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992–1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 10: 82–9.
- Singer M, Baer HA, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Rep. 1998; 113(Suppl 1): 81–9.
- Reich W, Compton WM, Horton JC, et al. Injection drug users report good access to pharmacy sale of syringes. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S68–72. CrossRef
- Garfein RS, Stopka TJ, Pavlinac PB, et al. Three years after legalization of non-prescription syringe sales in California (SB1159): where are we now? J Urban Health.
- Rose VJ, Backes G, Martinez A, McFarland W. Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions. J Urban Health.
- Backes G, Rose VJ. Primary and secondary analysis of local elected officials decisions to support or oppose pharmacy sale of syringes in California. J Urban Health.
- Cooper E, Dodson C, Stopka TJ, Riley ED, Garfein RS, Bluthenthal RN. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007. J Urban Health.
- Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. J Urban Health.
- Evaluating a Statewide Pilot Syringe Access Program for Injection Drug Users through Pharmacies in California
Journal of Urban Health
Volume 87, Issue 4 , pp 531-533
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links